Amryt Pharma plc reaffirmed revenue guidance for fiscal year 2022. For the year, the company is reaffirming revenue guidance for fiscal year 2022 in the range of $260 million - $270 million which represents growth of 17% to 21% on fiscal year 2021.
1st Jan change | Capi. | |
---|---|---|
+2.22% | 93.91B | |
-1.32% | 38.4B | |
-13.44% | 32.61B | |
+76.30% | 28.2B | |
-13.11% | 15.91B | |
+0.68% | 14.22B | |
-12.06% | 11.54B | |
+185.28% | 10.74B | |
-53.00% | 9.47B |